MOMS Project Panel Overview

Similar documents
The Impact of Addiction on Infant Mortality

Ohio Perinatal Quality Collaborative

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Mental and Behavioral Health

Smoke Free Families Informational Webinar August 23, 2018

Neonatal Abstinence Syndrome (NAS)

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Opioid Abuse Treatment in Pregnancy

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

EI Leadership April 24, 2018

Welcome to the OPQC NAS November Action Period Call

Effects of Prenatal Illicit Drug. Use on Infant and Child

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Substance-Exposed Newborns

Opiate Abuse and the Growing Impact on Maternal and Child Health in West Virginia. Overview

Child Welfare and MOMS: Building Partnerships to Improve Care

Perinatal Opioid Use: Understanding and Aligning Response between Systems

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Clinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP

New Jersey Mental Health and Addiction Providers Meeting April 26, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health

Methadone and Pregnancy

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

MATERNAL MORTALITY IN TEXAS Using Precision Public Health to Improve Maternal Outcomes

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

The Opioid-Exposed Woman

The Role of Opioid Overdoses in Confirmed Maternal Deaths,

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

Substance-Exposed Newborns

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

Neonatal Abstinence Syndrome: Focus on Prevention and Role of Collaboratives

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Opioid Addiction Statistics

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy

Outcomes of Infants with Neonatal Abstinence Syndrome

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

Presented by DCF SunCoast Region: Kyle Teague, Melissa Worthen, Christina Cuoco, Nina Romeu, Dekesha Seay

Neonatal Narcotic Abstinence Syndrome: A National Epidemic

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Safe Babies Foster Parent Training Program

Successful Prevention Strategies to Address the Opioid Crises

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

... Health. Department of. Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN. Overview and Regional Snapshot

OPQC Learning Session: High Risk Moms & Infants. Mary Applegate, MD, FACP, FAAP Medical Director, Ohio Department of Medicaid September 2016

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Creating a Safety Net for HIV Exposed Infants in Illinois

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

Lorain County Community Health Improvement Plan Annual report

Why NAS? Proposed Program

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse

Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis

Opioid Use and Other Trends

Prescription for Disaster: Impact of Drugs in our Society

Addressing Substance Use Among Pregnant Women and New Moms

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

PERINATAL TOBACCO USE

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

If so, when: Demographic Information Male Transgender Height: Weight: Massachusetts Resident? Primary Language: Are you currently homeless?

Medication for the Treatment of Addiction (MAT)

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome

State Options for Promoting Recovery among Pregnant and Parenting Women with Opioid or Substance Use Disorder

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

2/24/2014. Bridging the Gap Between Behavioral Health and Pregnancy. My Background and Interest in the Topic... Plan for Today

TITLE V MATERNAL & CHILD HEALTH 5-YEAR STATE ACTION PLAN

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Neonatal Abstinence: The epidemic Its Impact on All of Us

Indiana CTSI Retreat 2018

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem

Combating the Opiate Crisis in Ohio

in Illinois Illinois Department of Public Health Perinatal Rapid Testing Initiative for Illinois (PRTII2)

HELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES

Stark County Opiate Task Force

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center

Washington State s Overdose Epidemic

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

State Opioid Response (SOR) Grant

Prenatal Substance Abuse: Improving Outcomes

Wang Linhong, Deputy Director, Professor National Center for Women and Children s Health, China CDC

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

David S. McKenna, M.D. Dayton/Montgomery County Infant Mortality Coalition Maternal-Fetal Medicine Miami Valley Hospital, Dayton OH

Brief History of Methadone Maintenance Treatment

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

NEONATAL ABSTINENCE SYNDROME. NAS Kickoff 11/8/18

PERINATAL HEPATITIS B

Managing drug misuse in pregnancy and beyond

Opiate Use in Reproductive Age Females

Hospital Discharge Data

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment

Glenbeigh 2017 CHNA Implementation Strategy

Transcription:

MOMS Project Panel Overview Rick Massatti, PhD, Ohio Department of Mental Health and Addiction Services Jennifer Bailit, MD, MetroHealth Medical Center Mike Marcotte, MD, Tri-Health Mona Prasad, DO,MPH, -OSU-MCH Through collaborative use of improvement science methods, reduce preterm births & improve perinatal and preterm newborn outcomes in Ohio as quickly as possible.

MOMS Project

Maternal Opiate Medical Supports In August 2013, the Kasich Administration announced plans to address the epidemic of NAS Maternal Opiate Medical Supports (MOMS) project is a two-year quality improvement initiative that seeks to: Improve maternal and fetal outcome Improve family stability Reduce costs of Neonatal Abstinence Syndrome (NAS)

Project Partners State Sponsors Office of Health Transformation Department of Mental Health and Addiction Services Department of Medicaid Pilot Sites CompDrug First Step Home Health Recovery Services MetroHealth Medical Center Clinical Advisory Panel Project Management and Data Infrastructure Ohio Colleges of Medicine Government Resource Center Quality Improvement Vendor Health Services Advisory Group

Project Details $4.2 million program over two years Goal was to support interventions and prenatal treatments that improve outcomes for 300 women and babies Funded clinical (e.g., MAT) and non-clinical services (e.g., housing vouchers, transportation, brief babysitting)

Neonatal Abstinence Syndrome in Ohio Rick Massatti, PhD

Methods Ohio Hospital Association Statewide clinical and financial database Data submitted by 219 hospitals and 13 health systems. Approximately 99 percent of healthcare systems submit data A few caveats... Aggregate data used Analyses limited to resident Ohioans

Neonatal Abstinence Syndrome (NAS) Hospitalizations for NAS Cases were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM) code 779.5 (drug withdrawal syndrome in a newborn). Records for infants (age < 1) were pulled if they had applicable ICD-9 CM codes anywhere in discharge fields related to the primary diagnosis or any of the 18 secondary diagnosis fields. The ICD-9 CM code does not distinguish between NAS caused by drugs ingested by the mother versus NAS caused by drugs legitimately given by delivering physicians. The diagnosis of NAS does not include a diagnosis of Fetal Alcohol Spectrum Disorder (ICD-9 CM 760.71).

Mother s Drug Abuse at Child s Birth Over 28,800 women were diagnosed with a variety of drug abuse and dependence conditions at their time of delivery between 2004 and 2014. The number of delivering women with an abuse or dependence diagnosis increased from 1,554 in 2004 to 4,349 in 2014 (179.9%). Annual diagnosis rates for delivering mothers tripled from 103 per 10,000 live births in 2004 to 310 per 10,000 live births in 2014.

Drug Diagnoses at Child s Birth 3,000 2,500 Number of Diagnoses 2,000 1,500 1,000 Marijuana Opiate Cocaine Other* 500 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Year A woman could have multiple diagnoses * Other may refer to drugs like hallucinogens and amphetamines Source: Ohio Hospital Association

NAS in Ohio Increased opiate use led to the increased prevalence of NAS In 2014, there were 1,875 NAS inpatient admissions according to the Ohio Hospital Association.

NAS Statewide Rate per 10k 160 140 134 120 108 121 Rate per 10,000 100 80 60 50 70 88 40 20 14 19 21 25 33 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Year Source: Ohio Hospital Association

Rate Comparison per 10k 160 140 120 100 80 60 40 20 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 NAS Rate MOMS Rate 350 300 250 200 150 100 50 0 Source: Ohio Hospital Association

NAS Cost As NAS cases became more prevalent, inflationadjusted total inpatient costs associated with NAS increased. From $6.5 million in 2004 to $105.2 million in 2014

NAS Length of Stay (LOS) 25 20 19.5 20.1 19.6 18.9 Average LOS (days) 15 10 15.6 14.6 16.0 15.9 14.0 14.8 13.7 5 3.3 3.4 3.4 3.5 3.5 3.6 3.6 3.6 3.7 3.7 3.7 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Year Source: Ohio Hospital Association NAS Infants All Infants

Health Outcomes NAS Infants Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Feeding difficulties Low birth weight Respiratory symptoms Seizure & Convulsion All Ohio Infants Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Feeding difficulties Low birth weight Respiratory symptoms Seizure & Convulsion An infant could have multiple diagnoses Source: Ohio Hospital Association

Health Outcomes NAS Infants Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Feeding difficulties 20.80% 20.60% 23.00% 20.70% 22.00% 20.71% 18.51% 16.55% 15.29% 16.73% Low birth weight 32.00% 28.80% 32.30% 25.60% 29.10% 32.04% 26.85% 26.19% 25.48% 25.31% Respiratory symptoms 36.80% 37.70% 40.30% 35.50% 36.20% 30.31% 29.80% 23.25% 24.76% 22.79% Seizure & Convulsion 3.00% 3.10% 2.70% 2.30% 2.60% 1.83% 1.13% 1.40% 0.90% 1.39% All Ohio Infants Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Feeding difficulties 3.10% 3.30% 3.40% 3.60% 3.70% 4.10% 4.31% 4.44% 4.85% 4.79% Low birth weight 11.10% 11.30% 11.70% 11.50% 11.60% 12.10% 11.90% 12.30% 12.39% 12.74% Respiratory symptoms 10.00% 10.00% 9.90% 9.80% 9.80% 10.10% 9.85% 9.88% 9.81% 10.02% Seizure & Convulsion 0.30% 0.30% 0.30% 0.20% 0.20% 0.20% 0.22% 0.22% 0.22% 0.19% An infant could have multiple diagnoses Source: Ohio Hospital Association

19

20

21

22

23

NAS Rate by OPQC Region 45 40 35 30 25 20 15 10 5 0 Based on Patient Residence 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Akron/Canton/Youngstown (Northeastern) Toledo (Northwestern) Cincinnati (Western) Dayton (Southwestern) Cleveland (North Central) Appalachia (Southeastern) Columbus (Central) Source: Ohio Hospital Association

Raw Numbers by OPQC Region 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Akron/Canton/ Youngstown (Northeastern) 31 41 54 70 63 102 172 195 269 274 Cleveland (North Central) 35 33 49 54 64 81 92 111 131 150 Toledo (Northwestern) 20 14 17 18 19 42 41 72 102 162 Appalachia (Southeastern) 10 24 16 23 48 70 65 174 279 302 Cincinnati (Western) 46 60 60 65 79 115 166 224 207 237 Columbus (Central) 37 60 70 81 131 210 313 303 354 435 Dayton (Southwestern) 21 40 44 60 77 102 109 112 131 151 Source: Ohio Hospital Association

Contact Information Rick Massatti, PhD, MSW, MPH, LSW Ohio Dept. of Mental Health & Addiction Services 30 East Broad Street, 36 th Floor Columbus, Ohio 43215-2556 Phone (614) 752-8718 Rick.Massatti@mha.ohio.gov

Mother and Child Dependency Program MetroHealth Medical System Hospital based program Care coordination and social work Pediatrics (neonatal and community based) MAT provided by community, not at MetroHealth ~180 women in a year o 56% have Hepatitis C o 41.4% had previous children in DCFS custody o 33.8% were victims of assault o 12% admitted to prostitution o 90% have used heroin o 61% starting with Rx opioids o 27% are positive for opiates at delivery

Cincinnati MOMS Project Maternal Addiction Program Behavioral Health Therapy Inpatient/ Residential Care Intensive Outpatient Therapy Wrap Around Services HOPE Prenatal Care/ Case Management Inpatient MAT induction Referral to community MAT and addiction treatment Enhanced Prenatal Care Delivery Enhanced Postpartum Care Medication Assisted Treatment Medication Assisted Treatment Outpatient Buprenorphine Therapy Addiction Medicine

MOMS Franklin County Partners MRC Clinic

Questions for the Panelists